DNA Methylation Could Predict Ovarian, Breast Cancers
DNA Methylation Could Predict Ovarian, Breast Cancers
A pair of new studies finds that analyzing material from a Pap smear can reveal tumor risk in distant parts of the body, potentially allowing early interventions.
A pair of new studies finds that analyzing material from a Pap smear can reveal tumor risk in distant parts of the body, potentially allowing early interventions.
brca
New Guidelines Expand BRCA Screening
Ashley P. Taylor | Aug 21, 2019 | 2 min read
US Preventive Services Task Force recommends genetic testing for mutations in the cancer-related genes for more—but not all—women.
PARP Inhibitors Are Improving the Outlook of Hard-to-Treat Cancers
Vicki Brower | Apr 1, 2018 | 9 min read
With three recent FDA approvals, and a number of Phase 3 trials ongoing, the drugs are seeing a surge in interest.
Opinion: No, FDA Didn’t Really Approve 23andMe’s BRCA Test
Cecile Janssens | Mar 19, 2018 | 3 min read
Rather, the breast cancer mutation screen was classified as a type of medical device with obligations for the company to reduce risks to customers.
First Direct-to-Consumer BRCA Test Authorized by FDA
Kerry Grens | Mar 6, 2018 | 2 min read
The agency gave personal genomics company 23andMe the green light to screen samples for breast cancer–related genetic mutations.